BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 32106239)

  • 61. Fluid-attenuated inversion recovery diffusion-weighted imaging (DWI) for evaluating chemotherapy response in patients with acute leukemia: Comparison with conventional DWI.
    Tian X; Niu J; Li W; Zhou XJ; Wu W; Li X; Wang J; Wang H
    Indian J Cancer; 2022; 59(2):230-235. PubMed ID: 34380856
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Relevance of diffusion-weighted imaging with background body signal suppression for staging, prognosis, morphology, treatment response, and apparent diffusion coefficient in plasma-cell neoplasms: A single-center, retrospective study.
    Yamada A; Araki Y; Tanaka Y; Otsuki S; Yamada A; Moriyama M; Katagiri S; Suguro T; Asano M; Yoshizawa S; Akahane D; Furuya N; Fujimoto H; Okabe S; Gotoh M; Suzuki K; Saito K; Gotoh A
    PLoS One; 2021; 16(7):e0253025. PubMed ID: 34242226
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Dynamic contrast-enhanced magnetic resonance imaging for assessment of antiangiogenic treatment effects in multiple myeloma.
    Merz M; Ritsch J; Kunz C; Wagner B; Sauer S; Hose D; Moehler T; Delorme S; Goldschmidt H; Zechmann C; Hillengass J
    Clin Cancer Res; 2015 Jan; 21(1):106-12. PubMed ID: 25351744
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Assessing response of myeloma bone disease with diffusion-weighted MRI.
    Messiou C; Giles S; Collins DJ; West S; Davies FE; Morgan GJ; Desouza NM
    Br J Radiol; 2012 Dec; 85(1020):e1198-203. PubMed ID: 23175485
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Detection of bone metastases in non-small cell lung cancer patients: comparison of whole-body diffusion-weighted imaging (DWI), whole-body MR imaging without and with DWI, whole-body FDG-PET/CT, and bone scintigraphy.
    Takenaka D; Ohno Y; Matsumoto K; Aoyama N; Onishi Y; Koyama H; Nogami M; Yoshikawa T; Matsumoto S; Sugimura K
    J Magn Reson Imaging; 2009 Aug; 30(2):298-308. PubMed ID: 19629984
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Combining Deep Learning and Radiomics for Automated, Objective, Comprehensive Bone Marrow Characterization From Whole-Body MRI: A Multicentric Feasibility Study.
    Wennmann M; Klein A; Bauer F; Chmelik J; Grözinger M; Uhlenbrock C; Lochner J; Nonnenmacher T; Rotkopf LT; Sauer S; Hielscher T; Götz M; Floca RO; Neher P; Bonekamp D; Hillengass J; Kleesiek J; Weinhold N; Weber TF; Goldschmidt H; Delorme S; Maier-Hein K; Schlemmer HP
    Invest Radiol; 2022 Nov; 57(11):752-763. PubMed ID: 35640004
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Feasibility and clinical value of whole body diffusion weighted magnetic resonance imaging in detection of bone metastases].
    Li S; Xue HD; Sun F; Jin ZY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Apr; 31(2):192-9. PubMed ID: 19507599
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Comparison of whole-body diffusion MRI and conventional radiological assessment in the staging of myeloma.
    Narquin S; Ingrand P; Azais I; Delwail V; Vialle R; Boucebci S; Tasu JP
    Diagn Interv Imaging; 2013 Jun; 94(6):629-36. PubMed ID: 23683788
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Prediction of Abnormal Bone Density and Osteoporosis From Lumbar Spine MR Using Modified Dixon Quant in 257 Subjects With Quantitative Computed Tomography as Reference.
    Zhao Y; Huang M; Ding J; Zhang X; Spuhler K; Hu S; Li M; Fan W; Chen L; Zhang X; Li S; Zhou Q; Huang C
    J Magn Reson Imaging; 2019 Feb; 49(2):390-399. PubMed ID: 30390360
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Intravoxel Incoherent Motion Diffusion-weighted Imaging of Multiple Myeloma Lesions: Correlation with Whole-Body Dynamic Contrast Agent-enhanced MR Imaging.
    Bourillon C; Rahmouni A; Lin C; Belhadj K; Beaussart P; Vignaud A; Zerbib P; Pigneur F; Cuenod CA; Bessalem H; Cavet M; Boutekadjirt A; Haioun C; Luciani A
    Radiology; 2015 Dec; 277(3):773-83. PubMed ID: 26131910
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Simplified response monitoring criteria for multiple myeloma in patients undergoing therapy with novel agents using computed tomography.
    Schabel C; Horger M; Kum S; Weisel K; Fritz J; Ioanoviciu SD; Bier G
    Eur J Radiol; 2016 Dec; 85(12):2195-2199. PubMed ID: 27842666
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Multiparametric Whole-body MRI with Diffusion-weighted Imaging and ADC Mapping for the Identification of Visceral and Osseous Metastases From Solid Tumors.
    Jacobs MA; Macura KJ; Zaheer A; Antonarakis ES; Stearns V; Wolff AC; Feiweier T; Kamel IR; Wahl RL; Pan L
    Acad Radiol; 2018 Nov; 25(11):1405-1414. PubMed ID: 29627288
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Role of whole-body diffusion weighted imaging (WB-DWI) in the diagnosis and monitoring of newly diagnosed multiple myeloma].
    Wang PF; Li YC; Xu Y; Wang XM; Guo L; Fu CC
    Zhonghua Xue Ye Xue Za Zhi; 2017 Feb; 38(2):129-133. PubMed ID: 28279037
    [No Abstract]   [Full Text] [Related]  

  • 74. Improved Follow-Up and Response Monitoring of Thoracic Cage Involvement in Multiple Myeloma Using a Novel CT Postprocessing Software: The Lessons We Learned.
    Bier G; Mustafa DF; Kloth C; Weisel K; Ditt H; Nikolaou K; Horger M
    AJR Am J Roentgenol; 2016 Jan; 206(1):57-63. PubMed ID: 26700335
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Signal characteristics of normal adult bone marrow in whole-body diffusion-weighted imaging.
    Cui FZ; Cui JL; Wang SL; Yu H; Sun YC; Zhao N; Cui SJ
    Acta Radiol; 2016 Oct; 57(10):1230-7. PubMed ID: 26787674
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Percentage fat fraction in magnetic resonance imaging: upgrading the osteoporosis-detecting parameter.
    Chang R; Ma X; Jiang Y; Huang D; Chen X; Zhang M; Hao D
    BMC Med Imaging; 2020 Mar; 20(1):30. PubMed ID: 32183731
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Fat fraction quantification of lumbar spine: comparison of T1-weighted two-point Dixon and single-voxel magnetic resonance spectroscopy in diagnosis of multiple myeloma.
    Pei XJ; Lian YF; Yan YC; Jiang T; Liu AJ; Shi QL; Pan ZY
    Diagn Interv Radiol; 2020 Sep; 26(5):492-497. PubMed ID: 32755881
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Apparent diffusion coefficient measurements of bone marrow infiltration patterns in multiple myeloma for the assessment of tumor burden - a feasibility study.
    Xiong X; Ma Y; Dai Y; Hu C; Zhang Y
    Radiol Oncol; 2023 Dec; 57(4):455-464. PubMed ID: 38038425
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Diagnostic performance of
    Basha MAA; Hamed MAG; Refaat R; AlAzzazy MZ; Bessar MA; Mohamed EM; Ahmed AF; Tantawy HF; Altaher KM; Obaya AA; Afifi AHM
    Jpn J Radiol; 2018 Jun; 36(6):382-393. PubMed ID: 29671193
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Diagnostic value of whole-body ultra-low dose computed tomography in comparison with spinal magnetic resonance imaging in the assessment of disease in multiple myeloma.
    Ippolito D; Talei Franzesi C; Spiga S; Besostri V; Pezzati S; Rossini F; Sironi S
    Br J Haematol; 2017 May; 177(3):395-403. PubMed ID: 28233900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.